OSE_1309_part2_Layout 1 9/6/13 12:24 PM Page 126
A B D O M I N A L
S U R G E R Y
Perhaps the biggest splash in the mesh market over the past decade
or so was the advent of biological-based meshes. For this product, tissue extracted from pigs, cattle, human cadavers or other large animals is processed to remove the cells, leaving only a collagen scaffold
onto which a recipient patient's cells build a scar plate. The goal is for
the mesh to do the job, then go away without any ill after-effects.
Biological mesh has seen some successes, but its most advantageous
indication seems to be for use in an abdomen contaminated with significant bacterial infection. There's less worry that the mesh will
become infected in that type of salvage situation, since antibiotics can
get into the biological implant when tissue grows into it. With synthetic
mesh, into which blood vessels will never grow, antibiotics can't reach
the mesh where bacteria may have colonized.
100 degrees of articulation
to center mesh over defect
High visibility orange marking
indicates center of mesh2
Innovation that matters
AccuMesh™ Positio
AccuMesh Positioning System
For Laparoscopic Ventral H
For Laparoscopic Ventral Hernia Repair
| HERNIA CARE | MESH FIXATION PERMACOL™ DISSECTION
FIXAT
ATION PE
1
Pre-clinical lab data compared to current mesh placement technique
current mesh placement technique
Product Specification
2
COVIDIEN, COVIDIEN with logo, COVIDIEN logo and positive results for life are U.S. and internationally registered trademarks of Covidien AG.
COVIDIEN, CO
™*
Trademark
Trademark of its respective owner. Other brands are trademarks of a Covidien company. ©2013 Covidien 8.13 M121215a
